GENE ONLINE|News &
Opinion
Blog

NGS
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Precision Medicine Forum Gathers Experts to Pioneer Taiwan’s Personalized Cancer Care
2023-10-05
Prenetics Announces Acquisition of ACT Genomics, Aiming for the Multi-billion Market of Precision Oncology
2022-12-21
Fifth Wave of COVID-19 Devastates Hong Kong – How Next-Generation Sequencing Can Help with Latest Outbreak
2022-03-08Partner
The Golden Age of Genomics Sequencing
2022-02-20Partner
Oxford Nanopore Gears Up for Highly-Anticipated LSE IPO
2021-09-03
The Future of Precision Medicine: From Gene Therapy to Data Sharing Boom – Excerpts from the US-Taiwan Precision Medicine Forum
2021-07-21Partner
Precision Oncology: Overview of Diagnostic Technologies
2021-05-25
DiaCarta Unveils a Rapid, Highly Specific Technology to Detect COVID-19 Variants
2021-04-23
M&A
FTC Blocks Illumina’s $7 Billion Acquisition Bid to Restrict Monopoly of Cancer Diagnostic Market
2021-04-01
Illumina Looks to Consolidate NGS Market in APAC Region, Collaborates with Geneseeq to Develop IVD Kits in China
2021-03-21
FMI Empowers its Genomic Cancer Testing by Licensing TwinStrand’s Duplex Sequencing Technology
2020-11-18
Foundation Medicine’s Liquid Biopsy Test Bags FDA Approval for Eighth Indication as Companion Diagnostic
2020-11-10
Pioneering Nanopore Sequencing-Based COVID Diagnostic Bags Emergency Use Approval
2020-09-27
FDA Okays Foundation Medicine’s Comprehensive Liquid Biopsy Test
2020-08-27
1 2 3
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top